SC II Acquisition Corp. (SCIIU) Stock Price & Analysis
SC II Acquisition Corp. (SCIIU) closed at USD 10.3 on Wednesday, October 14, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 10.3; the Oct 14, 2026 session ranged USD 10.3–10.3 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 10.03–11.3 (NGM). Source: Nexqual, retrieved October 16, 2026 at 06:42 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SCIIU.md
Key facts (SCIIU)
- Analysts: None.
- Total return with dividends: 1Y +2.6% vs S&P 500 +18.1%; 5Y +2.7% vs S&P 500 +85.1%.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (SCIIU)
Analysts (SCIIU)
Consensus None.
Total return (dividends reinvested) (SCIIU)
| 1Y (from 2025-11-26) | 5Y (from 2025-11-24) | |
|---|---|---|
| Total return | +2.6% | +2.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 3.8% | 3.6% |
| Max drawdown | -1.3% (Sep 2026→Sep 2026) | -1.3% (Aug 2026→Sep 2026) |
Key Statistics (as of October 16, 2026 at 06:42 UTC)
| Price | USD 10.3 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.3 |
| Open | USD 0 |
| Day Range | USD 10.3 – 10.3 |
| 52-Week Range | USD 10.03 – 11.3 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (SCIIU)
Nexqual's technical model rates SCIIU "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of October 16, 2026 at 06:42 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.26 (neutral) |
| vs SMA50 | Above (USD 10.27) |
| MACD | 0.01 (positive) |
Analyst Ratings (SCIIU)
Wall Street analysts rate SCIIU "None", per Nexqual as of October 16, 2026 at 06:42 UTC.
| Consensus Rating | None |
|---|
Earnings (SCIIU)
Source: Nexqual, October 16, 2026 at 06:42 UTC.
Financials & Fundamentals (SCIIU)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 4.77 |
| Total Cash | $751,003 |
| Total Debt | $0 |
Source: Nexqual, October 16, 2026 at 06:42 UTC.
Financial Health Score (SCIIU)
Nexqual rates SC II Acquisition Corp.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 06:42 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $751K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$497K (TTM) |
| Efficiency | Mixed — No data |
Ownership (SCIIU)
| Insider Ownership | +1.46% |
|---|---|
| Institutional Ownership | +6.22% |
| Shares Outstanding | 15.26M |
| Float | 14.29M |
Source: Nexqual, October 16, 2026 at 06:42 UTC.
Leadership (SCIIU)
SC II Acquisition Corp. is led by Menachem Shalom (age 50), CEO & Chairman, per Nexqual as of October 16, 2026 at 06:42 UTC.
| CEO & Chairman | Menachem Shalom (age 50) |
|---|---|
| Chief Financial Officer | Asaf Yarkoni (age 50) |
Major Backers & Investors (SCIIU)
Notable institutional backers of SC II Acquisition Corp. include Yakira Capital Management, Inc., Toronto Dominion Bank, HGC Investment Management Inc., according to Nexqual as of October 16, 2026 at 06:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Yakira Capital Management, Inc. | 2.81% |
| Toronto Dominion Bank | 1.67% |
| HGC Investment Management Inc. | 0.66% |
| RIVERNORTH OPPORTUNITIES FUND INC.-Rivernorth Opportunities Fund Inc | 0.65% |
| Lineage Point Capital LP | 0.6% |
| Clear Street Group Inc. | 0.42% |
| Prelude Capital Management LLC | 0.38% |
| Stoic Point Capital Management LLC | 0.38% |
Source: Nexqual, October 16, 2026 at 06:42 UTC.
From SC II Acquisition Corp.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- SC II Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VYLR | Vylor Inc. | USD 73.34 | ▼ 4.68% |
| DMII | Drugs Made In America Acquisiti | USD 10.19 | ▲ 0% |
| CCXI | Churchill Capital Corp XI | USD 11.35 | ▲ 1.7% |
| EVAC | EQV Ventures Acquisition Corp. | USD 10.3 | ▼ 0.1% |
| BCSS | Bain Capital GSS Investment Cor | USD 10.22 | ▼ 0.15% |
| CEPF | Cantor Equity Partners IV, Inc. | USD 10.26 | ▼ 0.24% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 06:42 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt